Meghmani Organics Ltd Stock Falls to 52-Week Low of Rs.51.5

Feb 20 2026 11:15 AM IST
share
Share Via
Meghmani Organics Ltd, a player in the Pesticides & Agrochemicals sector, has touched a new 52-week low of Rs.51.5 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.
Meghmani Organics Ltd Stock Falls to 52-Week Low of Rs.51.5

Stock Price Movement and Market Context

On 20 Feb 2026, Meghmani Organics Ltd’s share price reached Rs.51.5, its lowest level in the past year and an all-time low. This price point represents a sharp fall from its 52-week high of Rs.106.03, indicating a depreciation of over 51% within the last twelve months. Despite this, the stock outperformed its sector by 0.48% on the day, showing a modest recovery after two consecutive days of decline.

However, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained downtrend. This contrasts with the broader market, where the Sensex recovered sharply after a negative opening, closing at 82,845.26, up 0.42% and just 4% shy of its 52-week high of 86,159.02. Mega-cap stocks led the market rally, while Meghmani Organics’ performance lagged considerably.

Financial Performance and Profitability Concerns

Meghmani Organics’ financial metrics reveal underlying pressures contributing to the stock’s decline. The company’s operating profits have contracted at a compound annual growth rate (CAGR) of -17.31% over the past five years, reflecting weakening long-term earnings capacity. The latest quarterly profit after tax (PAT) stood at a loss of Rs.3.53 crores, a steep fall of 135.6% compared to the previous four-quarter average.

Interest expenses have increased significantly, with a 22.18% rise over nine months to Rs.71.38 crores, further straining profitability. The operating profit to interest ratio for the quarter is at a low 2.08 times, indicating limited cushion to cover interest obligations. This is corroborated by a poor average EBIT to interest ratio of -5.58, underscoring challenges in servicing debt efficiently.

Shareholder Returns and Valuation Metrics

Return on equity (ROE) remains subdued at an average of 6.03%, signalling modest profitability relative to shareholders’ funds. Return on capital employed (ROCE) is slightly more encouraging at 4.6%, suggesting some efficiency in capital utilisation. The company’s enterprise value to capital employed ratio stands at 0.9, indicating an attractive valuation relative to its capital base.

Despite the stock’s negative return of -27.92% over the past year, Meghmani Organics has seen a notable rise in profits by 183.8%, resulting in a low price-to-earnings-growth (PEG) ratio of 0.2. This divergence between profit growth and share price performance highlights market scepticism about the sustainability of earnings improvements.

While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!

  • - Strongest current momentum
  • - Market-cycle outperformer
  • - Aquaculture sector strength

Don't Miss This Ride →

Market Position and Institutional Holding

Meghmani Organics operates within the Pesticides & Agrochemicals industry, a sector that has seen mixed performance in recent times. The company’s market capitalisation grade is rated 3, reflecting a mid-tier size within its peer group. However, domestic mutual funds hold no stake in Meghmani Organics, a notable absence given their capacity for detailed research and active portfolio management. This lack of institutional interest may reflect reservations about the company’s current valuation or business outlook.

The stock’s Mojo Score stands at 14.0, with a Mojo Grade of Strong Sell as of 1 Jan 2026, downgraded from Sell previously. This rating reflects the company’s weak fundamental strength and ongoing financial pressures.

Comparative Performance and Benchmarking

Over the last year, Meghmani Organics has underperformed the Sensex significantly, delivering a negative return of -27.92% compared to the benchmark’s positive 9.35%. The stock has also lagged behind the broader BSE500 index in each of the past three annual periods, indicating consistent underperformance relative to the market.

While the Sensex trades below its 50-day moving average, the 50DMA remains above the 200DMA, signalling a generally positive medium-term trend for the benchmark. In contrast, Meghmani Organics remains entrenched below all major moving averages, underscoring its relative weakness.

Is Meghmani Organics Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Summary of Key Financial Indicators

Meghmani Organics’ financial profile is characterised by a combination of declining operating profits, rising interest costs, and subdued returns on equity. The company’s ability to cover interest expenses remains limited, with the operating profit to interest ratio at a low 2.08 times in the latest quarter. The negative PAT figure of Rs.3.53 crores for the quarter further highlights the earnings pressure.

Despite these challenges, the company’s valuation metrics such as EV to capital employed and PEG ratio suggest that the stock is trading at a discount relative to peers and historical averages. However, this valuation discount has not translated into positive price momentum, as reflected in the stock’s 52-week low and consistent underperformance against benchmarks.

Sector and Market Dynamics

The Pesticides & Agrochemicals sector has experienced varied performance, with some companies benefiting from favourable agricultural demand and input cost dynamics. Meghmani Organics’ current market position and financial metrics indicate that it has not capitalised on these sector tailwinds to the same extent as peers. The absence of domestic mutual fund holdings further emphasises the cautious stance taken by institutional investors.

In the broader market context, the Sensex’s recovery and proximity to its 52-week high contrast with Meghmani Organics’ downward trajectory, highlighting the stock’s relative weakness within the current market environment.

Conclusion

Meghmani Organics Ltd’s fall to a 52-week low of Rs.51.5 reflects a combination of financial headwinds, weak profitability metrics, and limited institutional interest. The stock’s sustained trading below all major moving averages and its Strong Sell Mojo Grade underline the challenges faced by the company. While valuation metrics indicate a discount relative to peers, the stock’s performance over the past year and its consistent underperformance against benchmarks illustrate the difficulties in regaining investor confidence at present.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News